MAPT and tauopathy: Thus, we treated each cell line (4R/4R or 3R/4R) with a sample that contained tau seeds derived from either recombinant sources or human tauopathy cases, waited 48 hours, and replated the cells onto 96-well plates, transducing the following day with the arrayed 4R tau variants.